Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Excess fat in this area is linked to numerous problems ranging from heart disease to insulin resistance and fatty liver disease
Several other Achieve phase 3 trials are being conducted, as well as several Attain trials examining the drug's usefulness in treating obese patients or overweight patients with at least one other underlying condition, such as hypertension or high cholesterol
Secondary endpoints included waist circumference, blood pressure, lipids, and glycemic markers
Yet to be approved by the FDA, its currently being synthesized illegally and sold through a sprawling gray market
& Hobson-Webb, L
2C) compared with the control group
US$ 22.45
US$ 28.99
US$ 28.99
US$ 28.86
US$ 20.50
US$ 28.99
US$ 23.29
US$ 28.01
